First results from a phase 1, first-in-human study of the Bruton's tyrosine kinase (BTK) degrader BGB-16673 in patients (pts) with relapsed or refractory (R/R) B-cell malignancies (BGB-16673-101) Meeting Abstract
| Authors: | Seymour, J. F.; Cheah, C. Y.; Parrondo, R.; Thompson, M. C.; Stevens, D. A.; Lasica, M.; Wang, M. L.; Kumar, A.; Trotman, J.; Alwan, M.; Ding, W.; By, K.; Tariq, B.; Chen, X.; Fabre, S.; Paik, J.; Agarwal, A.; Tam, C. S. |
| Abstract Title: | First results from a phase 1, first-in-human study of the Bruton's tyrosine kinase (BTK) degrader BGB-16673 in patients (pts) with relapsed or refractory (R/R) B-cell malignancies (BGB-16673-101) |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 4401 |
| Language: | English |
| ACCESSION: | WOS:001159740307147 |
| DOI: | 10.1182/blood-2023-180109 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
